Wuhan Keqian Biology Co.,Ltd (688526.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.05B |
| Enterprise Value | 6.87B |
| P/E Ratio | 18.18 |
| PEG Ratio | -0.62 |
| Price/Sales Ratio | 6.88 |
| Price/Book Ratio | 1.42 |
| Enterprise/Revenue | 6.72 |
| Enterprise/EBITDA | 15.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.38 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 950.29M |
| Revenue/Share | 1.8 |
| Gross Profit | 950.29M |
| EBITDA | 590.1M |
| Net Income | 417.38M |
| Diluted EPS | 0.9 |
Balance Sheet
| Total Cash | 2.57B |
| Total Cash/Share | 5.55 |
| Total Debt | 41.74M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.82 |
| Book Value Per Share | 8.69 |
Price History
| 52-Week Change | -29.81 |
| 52-Week High | 18 |
| 52-Week Low | 11.65 |
| Moving Average 50 Days | 12.74 |
| Moving Average 200 Days | 14.26 |
Statistics
| Average Volume | 1.53M |
| Shares Outstanding | 466.13M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.64 |
| Trailing Annual Dividend Yield | 5.19 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
